AFRM
KBC hit the buy button
Affirm investors got a fresh institutional breadcrumb on Friday: KBC Group NV said it boosted its stake in AFRM by 979.6%, scooping up 176,399 shares and taking its total to 194,406 shares. At roughly $14.47 million, that’s not pocket change — it’s the kind of move that says, “We’ll take another helping.”
Why you should care
For a stock like Affirm, which lives and dies by growth, credit quality, and vibes, big institutional buys can be a confidence signal. It doesn’t change the business, but it can reinforce the idea that bigger-money investors still think the downside isn’t as scary as the chart might suggest.
The bigger backdrop
This comes after Affirm posted a pretty solid quarterly beat — $0.37 in EPS versus $0.28 expected, with revenue up 29.6% year over year to $1.12 billion. So yes, the company is still expensive and volatile, but the market usually gives growth names extra runway when the numbers and narrative line up.
What’s next
The real near-term test is May 7, when investors get the next earnings/investor-event date on the calendar. Until then, headlines like this one are basically the market’s way of saying the story is still alive — and not just because a few analysts have shiny price targets.
Big picture: a single fund buying more shares doesn’t make a stock good, but it does remind you that institutional confidence in Affirm hasn’t exactly gone missing.